INTRODUCTION
============

Periodontal disease is common among adults and can lead to tooth loss. It is accompanied by destruction of tissues surrounding the teeth following an inflammatory reaction that results from the host immune response to oral bacteria \[[@B1]\]. A homeostatic balance with symbiotic microbiota is maintained in the oral cavity in healthy conditions, whereas the dysbiosis of oral microbiota causes inflammatory destruction of periodontal tissue \[[@B2]\]. It was recently suggested that dysbiotic microbiota have distinct functions and act as accessory, pathobiont, or keystone pathogens, and that all these bacterial types can affect the pathogenesis of periodontitis \[[@B3]\]. Therefore, the entire dysbiotic subgingival microbiota, rather than a single bacterium, influences the progression of periodontitis \[[@B2][@B3][@B4]\]. Understanding dysbiotic microbiota can provide useful insights into the pathogenesis, diagnosis, and treatment of periodontitis.

Even before the advent of next-generation sequencing (NGS) as a method of analyzing oral microbiota, substantial evidence emerged regarding differences in the microbial composition of subgingival plaque between healthy periodontal conditions and periodontitis. Research by Socransky et al. \[[@B5]\] was essential in understanding the association between the oral bacterial community and periodontal disease. In their study, the distribution of 40 species was analyzed in subgingival plaque, and they reported that the subgingival bacteria in patients with periodontitis were characterized by a relative decrease of *Actinomyces* and a relative increase of the red complex, whereas *Streptococci* and *Actinomyces* were predominant in the healthy gingiva, with a relatively low proportion of the red complex \[[@B5]\]. Several studies on the effects of periodontal treatment on the bacterial composition of subgingival plaque have shown that improved clinical outcomes may be obtained when the levels of periodontal pathogens are reduced and the proportions of health-associated bacteria are increased \[[@B6][@B7]\]. Targeted approaches, including DNA hybridization and polymerase chain reaction (PCR)-based analyses, have provided information with regard to changes at the individual species level, but have not been able to provide a comprehensive view of the microbial community. The analysis of oral microbiota using open-ended molecular analytic tests, such as NGS, can provide additional information to enhance our understanding of the role of microorganisms in periodontal health and disease.

There is an unmet need for simple, immediate forms of near-patient testing to diagnose periodontitis \[[@B8]\]. Saliva has become a focus as a near-patient diagnostic tool for monitoring periodontal health, as repeated sampling is relatively easy and noninvasive. However, as the saliva combines bacteria from all niches of the oral cavity, it is questionable whether differences in the salivary microbiota reflect periodontal disease status or changes following periodontal treatment.

Research into the oral microbiota using NGS has been performed predominantly via the analysis of subgingival plaque, whereas very few studies have analyzed the salivary microbiota. The present study examined the characteristics of the salivary microbiota in conditions of periodontal health and disease following nonsurgical periodontal treatment and analyzed which bacterial taxa were present at a relatively high rate in conditions of periodontal health or periodontitis.

MATERIALS AND METHODS
=====================

Participants and microbial sampling
-----------------------------------

Salivary samples were obtained from 4 periodontally healthy participants and 8 patients diagnosed with chronic periodontitis recruited from Ajou University Dental Hospital and Seoul St. Mary\'s Hospital. This study was approved by the Institutional Review Board for Human Subjects of Ajou University Dental Hospital (AJIRB-BMR-SMP-16) and Seoul St. Mary\'s Hospital (KC16TIMI0755). Informed consent was obtained from all participants. The 12 participants were included in an ongoing investigation of the diagnosis and treatment of periodontal disease. The participants had no history of systemic disease that could influence the prognosis of periodontitis, untreated caries, or orthodontic appliances, and they did not smoke. None of the participants were pregnant/breastfeeding or treated with antibiotic, antimicrobial, and/or anti-inflammatory drugs during the 3 months before the examinations and sampling. The inclusion criteria for the chronic periodontitis group were as follows: with all teeth divided into 4 quadrants, each quadrant had at least 2 teeth with a probing depth (PD) ≥5 mm and attachment loss of ≥3 mm, and participants must not have had received periodontal treatment in the last 2 years \[[@B9]\]. Participants in the healthy control group were required to have an average PD of \<3 mm and \<20% of sites presenting with bleeding on probing (BOP). Two examiners (Suk Ji and Youngkyung Ko) carried out the periodontal examinations and microbial sampling. All participants were instructed to avoid ingestion, rinsing, and oral hygiene measures for 1 hour prior to sampling. From each participant, approximately 3 mL of a non-stimulated whole saliva sample was obtained and stored at −80°C until DNA extraction. Clinical parameters were measured, including the plaque index (PI), PD, gingival recession, and BOP. Patients with periodontitis received nonsurgical periodontal treatment, and saliva sampling and measurements of clinical parameters were repeated 3 months after treatment.

DNA extraction, amplification of 16S rDNA, and Illumina sequencing
------------------------------------------------------------------

Of the saliva sample, 1 mL was centrifuged at 15,928×*g* for 5 min, and the pellet was transferred to ChunLab, Inc. (Seoul, Korea) for DNA extraction and sequencing analysis. DNA was extracted using a FastDNA SPIN Kit for Soil (MP Biomedicals, Santa Ana, CA, USA), and PCR amplification was performed using primers targeting the V3 and V4 regions of the 16S rRNA gene, as previously described \[[@B10]\]. The PCR products were sequenced with an Illumina MiSeq sequencing system at ChunLab, Inc.

Sequencing analysis and statistical analysis
--------------------------------------------

UCHIME \[[@B11]\] and the non-chimeric 16S rRNA database from EzBioCloud were used to detect chimera on reads that contained a \<97% best hit similarity rate. The taxonomic profile of the microbiome was analyzed and compared between the healthy and periodontitis groups and between pre-treatment and post-treatment in the periodontitis group using BIOiPLUG (<https://www.bioiplug.com/>), a web-based life information analysis cloud platform provided by ChunLab, Inc. The analysis was based on the relative abundance of each taxonomic group, and the results were reconstructed for this study. The comparison of the number of operational taxonomic units (OTUs), the Chao 1 index, the Shannon index, and the phylogenetic diversity among the healthy, pre-treatment, and post-treatment groups were performed using the Wilcoxon rank-sum test. Kruskal-Wallis H statistical analysis was conducted to evaluate the differences in the dominant OTUs between the healthy and periodontitis groups and between pre-treatment and post-treatment in the periodontitis group. The sum of the whole-mouth PI, PD, clinical attachment level (CAL), the count of sites with PD ≥5 mm, and the percentage of BOP of the full mouth were compared between healthy participants and those diagnosed with periodontitis using the Mann-Whitney *U* test, and those clinical parameters were compared in pre-treatment and post-treatment samples using the Wilcoxon test. Analyses were performed using SPSS version 20 (IBM Corp., Armonk, NY, USA). *P* values \<0.05 were considered to indicate statistical significance.

RESULTS
=======

Sample groups and clinical responses to treatment
-------------------------------------------------

Four periodontally healthy participants (1 man and 3 women) with a mean age of 41 years (range, 26--52 years) and 8 patients with chronic periodontitis (5 men and 3 women) with a mean age of 52 years (range, 38--58 years) were selected for microbiome analysis. In total, the 20 samples were divided into 3 groups (healthy, pre-treatment of periodontitis, and post-treatment of periodontitis). The clinical parameters of the 3 groups are detailed in [Table 1](#T1){ref-type="table"}. There were statistically significant differences in PI, PD, CAL, count of sites with PD ≥5 mm, and percentage of BOP of the full mouth between the healthy participants and the pre-treatment periodontitis participants and between the pre- and post-treatment samples ([Table 1](#T1){ref-type="table"}). Clinical improvements in all parameters were observed in the periodontitis group after 3 months of nonsurgical treatment.

###### Clinical characteristics of healthy participants and patients with periodontitis pre- and post-treatment

![](jpis-50-171-i001)

  Variables                            Periodontal health (n=4)   Chronic periodontitis (n=8)   
  ------------------------------------ -------------------------- ----------------------------- ------------
  The sum of whole-mouth PI^a,b)^      14 (1--38)                 45 (9--76)                    10 (2--34)
  PD^a,b)^                             2.1±0.22                   4.0±0.08                      2.8±0.21
  CAL^a,b)^                            2.6±0.15                   4.5±0.19                      3.7±0.28
  Count of sites with PD ≥5 mm^a,b)^   0.8±0.48                   41.5±5.20                     10.0±6.82
  \% BOP^a,b)^                         12.1±3.38                  68.4±9.92                     29.0±9.90

Values are presented as median (minimum--maximum) or mean±standard deviation.

PI: plaque index; PD: probing depth; CAL: clinical attachment level; BOP: bleeding on probing.

^a)^*P*\<0.05 by the Mann-Whitney *U* test between the healthy group and pre-treatment in the periodontitis group; ^b)^*P*\<0.05 by the Wilcoxon signed rank test between pre-treatment and post-treatment in the periodontitis group.

Taxa diversity of the samples
-----------------------------

From the 4 periodontally healthy, 8 pre-treatment, and 8 post-treatment bacterial communities, the average number of reads used for data analysis was 37,101 (range, 21,234--51,052 per sample) with an average length of 422 bp and an average number of OTUs per sample of 299. The number of OTUs, Chao 1 index (species richness index), and Shannon index (species evenness index) did not differ among groups ([Figure 1](#F1){ref-type="fig"}). However, the phylogenetic diversity of the pre-treatment group (median, 489.5) was significantly higher than that of the healthy group (median, 325.5) and the post-treatment group (median, 404.0) groups ([Figure 1](#F1){ref-type="fig"}).

![Comparison of the number of OTUs, Chao 1 index, Shannon index, and phylogenetic diversity. Saliva samples were collected from 4 periodontally healthy participants at baseline and from 8 subjects diagnosed with chronic periodontitis at baseline and 3 months following nonsurgical periodontal treatment. Each value is presented as a box plot. The top, middle, and bottom lines of the boxes represent the 25th, 50th (median), and 75th percentiles, respectively. The significance of differences among the 3 groups was evaluated using the Wilcoxon rank-sum test, and *P*\<0.05 was considered to indicate statistical significance. Only *P* values of \<0.05 are indicated. OTU: operational taxonomic unit.](jpis-50-171-g001){#F1}

Differential abundance of taxa in health and disease
----------------------------------------------------

To investigate differences in the composition of the salivary microbiota and to evaluate microbial changes following periodontal treatment, the relative abundance of each taxon was compared between the healthy and pre-treatment periodontitis group and between the pre- and post-treatment samples at the phylum, genus, and species levels ([Figures 2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}, [4](#F4){ref-type="fig"}). In total, 18 OTUs at the phylum level were identified. The distribution pattern of the top 10 phyla (comprising 99.90%--99.98% of the total counts) in each sample group is shown in [Figure 2A](#F2){ref-type="fig"}. The 5 most abundant phyla in all 3 groups were Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria, and Fusobacteria, which comprised 97.7%--98.9% of the total count. The level of Actinobacteria was twofold higher in the saliva of the healthy controls than in the periodontitis group (16.5% vs. 8.7%) ([Figure 2A](#F2){ref-type="fig"}), whereas the level of Spirochaetes was 143-fold higher in the periodontitis group than in the healthy control group (0.6% vs. 0.004%) ([Figure 2B](#F2){ref-type="fig"}). The levels of Spirochaetes, Synergistetes, and Tenericutes, which were dominant in the periodontitis group, significantly decreased following nonsurgical periodontal treatment ([Figure 2B](#F2){ref-type="fig"}).

![Differences between conditions of periodontal health and periodontitis at the phylum level. (A) Distribution pattern of the top 10 phyla in the healthy group and the pre-and post-treatment periodontitis groups. (B) Three phyla dominant in the periodontitis group compared with the healthy control group.\
^a)^*P*\<0.05 by the Kruskal-Wallis H test between the healthy and periodontitis (pre-treatment) groups; ^b)^*P*\<0.05 by the Kruskal-Wallis H test between the pre- and post-treatment periodontitis groups.](jpis-50-171-g002){#F2}

![Differences between conditions of periodontal health and periodontitis at the genus level. (A) Genera significantly more abundant in saliva samples from the pre-treatment periodontitis group than in those from the healthy group among genera with a distribution of \>0.05% in the untreated periodontitis group. (B) Genera significantly more abundant in saliva samples from the healthy group than in those from the pre-treatment periodontitis group among genera with a distribution \>0.01% in the healthy group.\
^a)^*P*\<0.05 was considered to indicate statistical significance by the Kruskal-Wallis H test between the pre- and post-treatment periodontitis.](jpis-50-171-g003){#F3}

![Differences between conditions of periodontal health and periodontitis at the species level. (A) Species significantly more abundant in saliva samples from the pre-treatment periodontitis group than in those from the healthy group among genera with a distribution \>0.05% in the periodontitis group. (B) Species significantly more abundant in saliva samples from the healthy group than in those from the pre-treatment periodontitis group among species with a distribution \>0.01% in the healthy group.\
^a)^*P*\<0.05 was considered to indicate statistical significant by the Kruskal-Wallis H test between the pre- and post-treatment periodontitis groups.](jpis-50-171-g004){#F4}

The results revealed that 28 genera and 62 species were significantly more abundant in the periodontal saliva than in the healthy saliva. By contrast, 5 genera and 10 species were more abundant in the healthy saliva. Among the genera and species exhibiting relative differences in abundance between periodontal health and disease, only those genera or species with a \>0.05% relative abundance in disease compared with healthy conditions and those with a \>0.01% relative abundance in healthy conditions compared with disease are presented in [Figures 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}.

The top 7 genera showing a high abundance in the saliva from the pre-treatment periodontitis group were *Peptostreptococcus*, *Treponema*, *Parvimonas*, *Tannerella*, *Campylobacter*, *Alloprevotella*, and *Filifactor* ([Figure 3A](#F3){ref-type="fig"}), whereas *Streptococcaceae*\_uc and *Akkermansia* were present at higher levels in the saliva from the healthy group than in the saliva from the pre-treatment periodontitis group ([Figure 3B](#F3){ref-type="fig"}). In particular, the relative abundance of *Treponema* in the pre-treatment periodontitis group was 134-fold higher than that of the healthy controls (0.6% vs. 0.004%) ([Figure 3A](#F3){ref-type="fig"}). The ratio of *Filifactor* in the periodontitis group was 0.3%, whereas that in the healthy controls was 0%. There was a trend for the genera dominant in periodontitis to decrease and for the genera dominant in health to increase following treatment. Significant differences between pre-treatment and post-treatment were found in *Treponema*, *Filifactor*, *Aggregatibacter*, *Aminicella*, *Fretibacterium*, *Mycoplasma_g4*, and 2 unclassified genera (*AM420159_g* and *JN713427_g*) among the genera dominant in untreated periodontitis, and in this group, the *Streptococcus anginosus* group and the *Streptococcus constellatus* group were also found. The genera dominant in healthy conditions included *Streptococcaceae*\_uc ([Figure 3B](#F3){ref-type="fig"}).

The top 8 species that were more abundant in diseased saliva included the *P. stomatis* group, *Porphyromonas gingivalis*, the *Fusobacterium nucleatum* group, *Parvimonas micra*, *Porphyromonas endodontalis*, *AY005065_s* (*Prevotella* genus), *Filifactor alocis*, and *Tannerella forsythia* ([Figure 4A](#F4){ref-type="fig"}). The abundance ratios of these species were 0.3%--1.73% in the periodontitis group and \<0.04% in the healthy group, with the exception of the *P*. *stomatis* group (0.2% in the healthy group). Among these 7 species, the distributions of *P*. *gingivalis* and *F*. *alocis* in healthy controls were zero. There was a trend for species dominant in periodontitis to decrease following treatment. Nine species, including *F*. *alocis* and *T*. *forsythia*, decreased significantly following treatment ([Figure 4A](#F4){ref-type="fig"}). Six species, including the *Streptococcus salivarius* group, were present at higher levels in healthy saliva than in diseased saliva, and the *S*. *salivarius* group increased in abundance following treatment ([Figure 4B](#F4){ref-type="fig"}).

DISCUSSION
==========

The present study examined the distribution and characteristics of the salivary microbiota in periodontal health and disease and their changes following nonsurgical periodontal treatment. Sequencing analysis of the 16S rRNA gene revealed that healthy and diseased saliva samples had compositionally distinct microbiota and that the samples of saliva from participants with periodontitis had more diverse microbiota than the samples from healthy participants. In patients with periodontitis, the phylum Spirochaetes and the genus *Treponema* were present at 143- and 134-fold higher levels than in healthy participants, respectively, and these taxa significantly decreased following periodontal treatment. The association between these 2 taxa and periodontitis has been well demonstrated \[[@B12][@B13][@B14]\]. Among the OTUs at the species level, the distributions of well-established periodontal pathogens of the *P*. *stomatis* group, *P*. *gingivalis*, the *F*. *nucleatum* group, and *T*. *forsythia* \[[@B2][@B3][@B5][@B13][@B15][@B16]\] were significantly higher than those in the healthy group. In addition, *P*. *micra*, *P*. *endodontalis*, and *F*. *alocis*, which have been reported as newly identified pathogenic bacteria in recent NGS studies \[[@B13][@B16][@B17]\], were also identified to be highly abundant in the periodontitis group. The phylum Actinobacteria, the genus *Streptococcaceae*\_uc, and the species *S*. *salivarius* group were found to be markedly more abundant in the samples from healthy participants than in the periodontitis group. The association between Actinobacteria and periodontal health is consistent with previous studies \[[@B13][@B15]\], and *S. salivarius* is frequently described as a commensal bacterium \[[@B18]\], with a strain of *S*. *salivarius* under trial for use as a probiotic for the prevention of oral infections \[[@B19]\]. These results show that the periodontitis- or health-associated bacteria identified through the analysis of subgingival plaque bacteria correspond closely to the salivary bacteria associated with periodontitis or healthy periodontal conditions in this study. Due to its simplicity and easy accessibility, saliva sampling has been suggested as a tool for monitoring periodontitis. Therefore, the taxa identified as health-associated or disease-associated may be used as candidate salivary biomarkers of periodontal health or disease.

The microbiota of the subgingival space has been the focus of research into the pathogenesis of periodontitis. However, the sampling of subgingival plaque is relatively complicated and requires more equipment and trained personnel. Our results show that the relative abundance of well-known health- or periodontitis-associated bacteria in the salivary microbiota closely parallels that of the subgingival microbiota in health or disease, as supported by recent NGS studies analyzing the association between subgingival and salivary microbiota. Periodontal pathogens observed at a high proportion in subgingival plaque were observed in saliva at levels correlated with their abundance in subgingival plaque \[[@B16][@B20]\]. Kageyama et al. \[[@B20]\] demonstrated that the relative abundance of subgingival plaque-specific bacteria in the salivary microbiota was closely correlated with the severity of periodontal disease. They concluded that the salivary microbiota may be a promising target for the evaluation of subgingival plaque-derived bacteria representing periodontal health. In addition, Belstrom et al. \[[@B16]\] compared the subgingival and salivary microbiota before and after periodontal treatment to determine whether changes in the subgingival microbiota were reflected in the salivary microbiota; it was concluded that the subgingival and salivary abundance of periodontal pathogens was correlated before and after treatment.

In research aiming to identify biomarkers for periodontitis using saliva, the levels of well-known pathogenic bacteria, including the 3 red complex species, are determined by targeting a specific region of the16S rRNA gene \[[@B21][@B22][@B23][@B24]\]. Multiple promising microbial biomarkers that correlate with the clinical parameters of periodontitis have been identified in saliva. Among them, *P. gingivalis*, *Prevotella intermedia*, and *T. forsythia* have been endorsed by multiple studies as potentially useful biomarkers of periodontitis \[[@B8]\]. In the present study, these 3 species were found to be more abundant in the saliva of patients with periodontitis than that of healthy participants.

An optimal biomarker can only be validated through large-scale analysis of the salivary microbiota of a large number of individuals. In the present study, the distribution of *P. gingivalis* was zero in all healthy controls, whereas patients with periodontitis had an average distribution of 1.35%, which decreased to 0.43% following treatment. Therefore, *P. gingivalis* in saliva can be considered as a strong candidate biomarker of periodontitis. However, *P. gingivalis* was not detected in 1 of the 8 patients with periodontitis. In addition, in another participant, the relative abundance of *P. gingivalis* increased following periodontal treatment, although the clinical parameters showed improvement ([Supplementary Figure 1](#S1){ref-type="supplementary-material"}). This result indicates that diagnosis based on a single species is not feasible, and it is instead suggested that diagnosing periodontitis based on the combined detection of multiple bacterial taxa in saliva is superior to diagnosing periodontitis based on the detection of a single bacterial species.

Relatively few reports have described changes in the salivary microbiota following periodontal treatment \[[@B14]\]. To date, only 1 paper has been published on changes in the salivary microbiome of periodontitis patients after periodontal therapy, and more studies are needed to uncover the whole picture of the salivary microbiome and periodontitis. Differences in the oral microbiome have been reported from even closely neighboring countries \[[@B25]\]. This is the first study to describe salivary microbiome changes in Koreans. Scaling and subgingival debridement disrupt the biofilm in the subgingival space and alter the number and composition of subgingival microbes \[[@B26]\]. This eventually attenuates inflammation in the periodontal tissues and reduces the depth of the periodontal pocket, resulting in ecological changes in the subgingival environment. These ecological changes are unfavorable to most periodontopathic bacteria and enable the change in composition of subgingival microbiota to be maintained for a longer period \[[@B27]\]. In the present study, we examined changes in the salivary microbiota 3 months after nonsurgical periodontal treatment. Reductions in the periodontal pockets and BOP were maintained, and clinical changes were accompanied by alterations in the composition of the salivary microbiota, with a decrease in the relative abundance of *P*. *gingivalis* (3-fold, 1.35% vs. 0.43%), *P*. *micra* (3-fold, 0.425% vs. 0.14%), *F*. *alocis* (4.5-fold, 0.3% vs. 0.07%), and *T*. *forsythia* (3.9-fold, 0.3% vs. 0.08%) and an increase in the relative abundance of the *S*. *salivarius* group (2.8-fold, 6.13% vs. 2.16%). This suggests that ecological changes in the subgingival environment are associated with sustained changes in the salivary microbiota. We did not detect in the salivary microbiome *Halomonas hamiltonii*, which was the microorganism most often discovered in Koreans with a healthy periodontium in a report by Park et al. \[[@B15]\]. This discrepancy may have resulted from differences in the sampled groups. An important finding of the present study was that there were distinctions in the taxa of the salivary microbiota between periodontal health and disease. The presence of *Streptococcus anginosus* group and the *Streptococcus constellatus* group in the saliva of periodontitis patients has not been reported previously, and further research should explore possible correlations of these taxa with periodontitis in the wider population. Well-known pathogenic and health-associated bacteria were confirmed to be highly related to periodontitis and health, respectively, making them suitable as candidate salivary biomarkers for periodontal health and disease. However, this study has limitations in that the sample size was small and the functional activity of the microbial community was not identified. Another limitation is that quantitative changes in specific bacteria were not analyzed according to participants' age or periodontitis progression. Large-scale, long-term follow-up studies are needed to observe the causal relationships between periodontopathic bacteria and disease progression.
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SUPPLEMENTARY MATERIAL
======================

###### Supplementary Figure 1

Differences in *Porphyromonas gingivalis* composition between pre- and post-treatment measurements of 8 patients with periodontitis. The relative abundance of *P*. *gingivalis* between the pre- and post-treatment periodontitis communities was compared.
